OKYO Pharma Limited logo

OKYO Earnings Date: Dec 2, 2026 (Estimated) — OKYO Pharma Limited

NASDAQ

Updated

Price $1.50
Market Cap $78.7M
P/E -5.9
52W Range $1.26 – $3.20
Next Earnings (est.)

When is OKYO's next earnings date?

OKYO Pharma Limited (OKYO) is expected to report earnings on Wednesday, December 2, 2026; the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.06.

How did OKYO do in its last earnings report?

In its most recent report on Jul 20, 2026 (FY 2026), OKYO Pharma Limited posted EPS of -$0.24 versus the -$0.13 estimate, a miss of 84.6%. Revenue was $0. The stock's 1-day post-earnings move was -4.2%.

How much does OKYO stock move after earnings?

OKYO beat EPS estimates in 0 of its last 1 reported quarter. Over the last 3 reports the stock moved an average of 6.3% (up or down) in the day after earnings.

About OKYO Pharma Limited

OKYO Pharma Limited is a biopharmaceutical firm operating at the preclinical stage, dedicated to developing innovative treatments for individuals in the United Kingdom experiencing inflammatory eye conditions and ocular discomfort. Its primary therapeutic candidate is OK-101, specifically designed to address dry eye disease. Additionally, the company is advancing OK-201, an experimental bovine adrenal medulla lipidated-peptide analogue, intended to treat neuropathic ocular pain. Established in 2007, OKYO Pharma Limited maintains its headquarters in London, UK.

Earnings History

DatePeriodEPS Est.EPS Act.SurpriseRevenueResult1D Δ1W Δ1M Δ
2026-07-20FY 2026-0.13-0.24-84.62%$0❌ Miss-4.20%+8.39%+6.29%
2024-08-13FY 2024—-0.57—$0—+2.35%+2.34%+6.45%
2023-05-17FY 2022—-0.01—$0—+12.26%-1.48%-16.45%
2022-09-30—-0.00——————
2022-03-31—-0.47——————
2021-09-30—-0.00——————
2021-03-31—-0.37——————
2020-09-30—-0.15——————

Showing last 8 quarters.

Learn More

Explore More

Financial data from licensed market-data providers; risk factors from SEC EDGAR filings. AI-powered analysis. Data last updated .